Michael Mager

Ben Rapoport and Michael Mager, co-founders of Precision Neuroscience, delve into the fascinating world of brain-computer interfaces (BCIs). They discuss using BCIs for revolutionizing stroke rehabilitation, decoding consciousness in coma patients, and treating depression with AI-driven neural biomarkers. The duo explores the potential to merge human cognition with machines, highlighting the ethical challenges and transformative possibilities. Their insights promise to change our understanding of the brain and reshape medical treatments.

Michael Mager, co-founder and CEO of Precision Neuroscience, discusses pioneering brain-computer interfaces designed to assist those with severe mobility issues. He shares the company's vision for making non-invasive brain implants available to millions and the challenges involved in competing with giants like Neuralink. Mager also reflects on recent FDA approvals and the potential for these technologies to revolutionize lives, turning once rare procedures into standard healthcare solutions.

Michael Mager, co-founder and CEO of Precision Neuroscience, leads development of safe, minimally invasive brain-computer implants. He explains how thin-film surface arrays work, contrasts non-penetrating vs penetrating designs, and describes wireless, rechargeable fully implanted systems. He discusses clinical use cases, temporary implants for bedside demos, training for paralyzed users, and timelines for permanent implants and regulation.